Boston, MA -- (SBWIRE) -- 12/04/2013 -- DiaSorin S.p.A. (DiaSorin) is a medical device company. It undertakes the development and manufacture of reagents pertaining to in-vitro diagnostics and systems that enable automatic diagnostic investigation. Its major product offerings include radio immuno assays (RIA), enzyme linked immunosorbent assays (ELISA) and chemiluminescent immuno assays (CLIA). The company also develops and distributes immune reagent kits for clinical diagnostics and equipment that are to be used in combination with reagents, to facilitate automatic diagnostic investigation. DiaSorin Group operates through 23 companies and five branches in Europe, the US, Central and South America and Asia. The company is headquartered at Saluggia, Vercelli, Italy.